Is interferon γ one key of metastatic potential increase in human bladder carcinoma?

Clinical Cancer Research

Volumn 9, Issue 12, 2003, Pages 4562-4569

  Champelovier, Pierre ^a,c   Simon, Annick ^b   Garrel, Catherine ^c   Levacher, Geraldine ^d   Praloran, Vincent ^e   Seigneurin, Daniel ^a  

^a Laboratoire de Cytologie   (France)

^b HÔpital Michallon   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d INSTITUT ALBERT BONNIOT   (France)

^e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BCG VACCINE; CASPASE 8; CASPASE 9; COLONY STIMULATING FACTOR 1; CYCLOHEXIMIDE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA CONVERTING ENZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UROKINASE RECEPTOR;

APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; DOSE RESPONSE; HUMAN; HUMAN CELL; METASTASIS; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; URINALYSIS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL DIVISION; CELL MOVEMENT; DRUG RESISTANCE, NEOPLASM; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERFERON TYPE II; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA; URINARY BLADDER NEOPLASMS;

EID: 0141960414     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Morales, A., Eidinger, D., and Bruce, A., W. Intracavity bacillus Calmette Guerin in the treatment of superficial bladder tumors. J. Urol., 116: 180-186, 1976.
2. Herr, H., Laudone, V. P., and Badalement, R. A. Bacillus Calmette Guerin therapy alters the progression of superficial bladder cancer. J. Clin. Oncol., 6: 1450-1455. 1988.
3. Patard, J. J., Saint, F., Velotti, F., Abbou, C. C., and Chopin, D. K. Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review. Urol. Res., 26: 155-159, 1998.
4. Prescott, S., James, K., and Hargreave, T. B. Radiommunoassay detection of interferon-gamma in urine after intravesical BCG therapy. J. Urol., 144: 1248-1252, 1990.
5. De Boer, E. C., De Jong, W. H., and Steerenberg, P. A. Induction of interleukins-1 (IL-1), 1L-2, IL-6 and tumor necrosis factor during intravesical immunotherapy with bacillus Calmette Guerin in superficial bladder cancer. Cancer Immunol. Immunother., 34: 306-311, 1992.
6. Taniguchi, K., Koga, S., Nishikido, M., Yamashita, S., Sakuragi, T., Kanetake, H., and Saito, Y. Systemic immune response after intravesical instillation of bacille Calmette Guerin (BCG) for superficial bladder cancer. Clin. Exp. Immunol., 115: 131-135, 1999.
7. De Reijke, T. M., Vos, P. C. N., de Boer, E. C., Bevers, R. F. M., de Muinck, W. H., Kurth, K. H., and Schahart, D. H. J. Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette Guerin (BCG). Urol. Res., 21: 349-352, 1993.
8. Zhang, Y., Khoo, H. E., and Esuvaranathan, K. Effects of bacillus Calmette Guerin and interferon a-2B on cytokine production in human bladder cancer cell lines. J. Urol., 161: 977-983, 1999.
9. Gohda, E., Takebe, T., Sotani, T., Nakamura, S., Minowada, J., and Yamamoto, I. Induction of hepatocyte growth factor/scatter factor by interferon γ in human leukemic cells. J. Cell. Physiol., 174: 107-114, 1998.
10. Matsuura, K., Otsuka, F., and Fujisawa, H. Effects of interferons on tumor necrosis factor production from human keratinocytes. Cytokine, 10: 500-505, 1998.
11. Park, D. S., Park, J. H., Lee, J. L., Lee, J. M., Kim, Y. H., Lee, J. M., and Kim, S. J. Induction of ICAM-1, HLA-DR molecules by IFN-γ and oncogene expression in human bladder cancer cell lines. Urol. Int., 59: 72-80, 1997.
12. Rosfjord, E. C., and Dickson, R. B. Growth factors, apoptosis and survival of mammary epithelial cells. J. Mammary Gland Biol. Neoplasia, 4: 229-237, 1999.
13. Prescott, S., James, K., Busuttil, A., Hargreave, T. B., Chisholm, G. D., and Smyth, J. F. HLA-DR expression by high grade superficial bladder cancer treated with BCG. B. J. Urol., 63: 264-269, 1989.
14. Fidelman, A. E., Bruckna, R. A., Kacinski, B. M., Deng, N., and Remold, H. G. Macrophage colony stimulating factor (CSF-1) enhances invasiveness in CSF-I receptor positive carcinoma cell lines. Cancer Res., 52: 3661-3666, 1993.
15. William, R. B. The fibrinolytic system in neoplasia. Semin. Thromb. Haemost., 76: 580-585, 1996.
16. Gohji, K., Nomi, M., Niitani, Y., Kitazawa, S., Fujii, A., Katsuoka, Y., and Nakajiima, M. Independent prognostic value of serum hepatocyte growth factor in bladder cancer. J. Clin. Oncol., 18: 2963-2971, 2000.
17. Ramani, P., and Balkwill, F. R. Enhanced metastases of a mouse carcinoma after in vitro treatment with murine interferon γ. Int. J. Cancer, 40: 830-834, 1987.
18. Kelly, S. A., Gschmeissner, S., East, N., and Balkwill, F. R. Enhancement of metastatic potential by γ-interferon. Cancer Res., 51: 4020-4027, 1991.
19. Fixe, P., Lorgeot, V., Le Meu, r, Y., Coupey, L., Heymann, D., Golard, A., and Praloran, V. Development of enzymo-immunoassays (EIA) for macrophage colony-stimulating factor (M-CSF) and leukemia inhibitory factor (LIF) by using the same capture and signal generating polyclonal antibody. Cytokine, 8: 586-590, 1996.
20. Champelovier, P., Richard, M. J., and Seigneurin, D. Autocrine regulation of TPA-induced apoptosis in monoblastic cell line U-937: role for TNF, MnSOD and IL-6. Anticancer Res., 20: 451-458, 2000.
21. Matsuura, K., Otsuka, F., and Fujisawa, H. Effects of interferons on tumor necrosis factor α production from human keratinocytes. Cytokine, 1: 500-505, 1998.
22. Manna, S. K., Zhang, H. J., Yan, T., Oberley, L. W., and Aggarwa, B. B. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kB and activated protein-1. J. Biol. Chem., 273: 3245-13254, 1998.
23. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N., and Hay, N. The PI3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Develop., 11: 701-713, 1997.
24. Meng, Q., Mason, J. M., Porti, D., Goldberg, I. D., Rosen, E. M., and Fan, S. Hepatocyte growth factor decreases sensitivity to chemotherapeutic agents and stimulates cell adhesion, invasion and migration. Biochem. Biophys. Res. Com., 274: 772-779, 2000.
25. Schamhart, D. H. J., de Boer, E. C., and de Reijke, T. M. Urinary cytokines reflecting the immunological response in the urinary bladder to biological response modifiers: their practical use. Eur. Urol., 37: 16-23, 2000.
26. Tanabe, K., Alexander, J. P., Steinbach, F., Campbell, S., Novick, A. C., and Klein, E. A. Retroviral transduction of intracellular adhesion molecule-I enhances endothelial attachment of bladder cancer. Urol. Res., 25: 401-405, 1997.
27. Hudson, M. A., and McReynold, L. M. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines. Adv. Exp. Med. Biol., 462: 399-412, 1999.
28. Champelovier, P., Boucard, N., Levacher, G., Simon, A., Seigneurin, D., and Praloran, V. Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor (u-PAR) and plasminogen activator inhibitor-type 2 (PAI2) using immunocytochemical method. Urol. Res. 3: 301-309, 2002.
29. Campbell, S. C., Tanabe, K., Alexander, J. P., Edinger, M., Tubbs, R. R., and Klein, E. A. Intercellular adhesion molecule-1 expression by bladder cancer cells: functional effects. J. Urol., 151: 1385-1390, 1994.
30. Sanda, M. G., Bolton, E., Mule, J. J., and Rosenberg, S. A. In vivo administration of recombinant macrophage colony-stimulating factor induces macrophage-mediated antibody-dependent cytotoxicity of tumor cells. J. Immunother., 12: 132-137, 1992.
31. Shin, K. Y., Moon, H. S., Park, H. Y., Lee, T. Y., Woo, Y. N., Kim, H. J., Lee, S. J., and Kong, G. Effects of tumor necrosis factor α and interferon γ on expressions of matrix metalloproteinase-2 and -9 in human bladder cancer cells. Cancer Lett., 159: 127-134, 2000.
32. Slaton, J. W., Karashima, T., Perrotte, P., Inoue, K., Kim, S. J., Izawa, S. J., Kedar, D., McConkey, D. J., Millikan, R., Sweeney, P., Yoshikawa, C., Shuin, T., and Dinney, C. P. N. Treatment with low-dose interferon-a restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. Clin. Cancer Res., 7: 2840-2853, 2001.
33. Burow, M. E., Weldon, C. B., Melnik, L. I., Duong, B. N., Collins-Burow, B. M., Beckman, B. S., and McLachlan, J. A. PI3-K/AKT regulation of NF-kB signaling events in suppression of TNF-induced apoptosis. B. B. R. C., 271: 342-345, 2000.
34. Prescott, S., James, K., Hargreave, T. B., Chisholm, G. D., and Smyth, J. F. Radio-immunoassay detection of interferon γ in urine after intravesical evans BCG therapy. J. Urol., 144: 1248-1251, 1990.
35. Morita, M., Watanabe, Y., and Akaike, T. Protective effect of hepatocyte growth factor on interferon γ-induced cytotoxicity in mouse hepatocytes. Hepatology, 21: 1585-1593, 1995.
36. Tamatani, T., Hattori, K., Lyer, A., Tamatani, K., and Oyassu, R. Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells. Carcinogenesis (Lond.), 20: 957-962, 1999.
37. Saiki, I., Murata, J., Saito, S., Higashi, N., and Azuma, I. Effect of systemic administration of mouse recombinant interferon γ on the lung tumor metastases in mice. Mol. Biother., 1: 261-267, 1989.
38. Meysken, F. L., Kopecky, K., Samson, M., Hersh, E., Macdonald, J., Jaffe, H., Crowley, J., and Coltman, C. Recombinant human interferon-γ: adverse effects in high-risk stage I and II malignant melanoma. J. Natl. Cancer Inst. (Bethesda), 82: 1071-1075, 1990.
39. Poppas, D. P., Pavlovich, C. P., Folkman, J., Voest, E., Chen, X., Luster, A. D., and O'Donnell, M. A. Intravesical bacille Calmette-Guerin induces the antiangiogenic chemokine interferon-inducible protein 10. Urology, 52: 268-275, 1998.
40. Hawkyard, S. J., Jackson, A. M., Hawkins, R. A., James, K., Smyth, J. F., and Chisholm, G. D. The expression of interferon γ receptors on bladder cancer cells: does it correlate with biological response? Urol. Res., 20: 229-232, 1992.
41. Saint, F., Patard, J. J., Maille, P., Soyeu, P., Hoznek, A., Salomon, L., de la Taille, A., Abbou, C. C., and Chopin, D. K. T helper1/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus Calmette-Guerin for superficial bladder cancer. J. Urol., 166: 2142-2147, 2001.
42. Rovida, E., Baccarini, M., Olivotto, M., and Dello Sbarba, P. Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages. Oncogenes, 21: 3670-3676, 2002.
43. Gutterman, J. Cytokine therapeutics: lessons from interferon α. Proc. Natl. Acad. Sci. USA, 91: 1198-1205, 1996.